欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NL/H/1340/003
药品名称
Adport 5 mg, capsules, hard
活性成分
TACROLIMUS ANHYDROUS 5.0 mg
剂型
Capsule, hard
上市许可持有人
Sandoz B.V. Veluwezoom 22 1327 AH Almere The Netherlands
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Belgium (BE)
United Kingdom (Northern Ireland) (XI)
Austria (AT)
France (FR)
Spain (ES)
Portugal (PT)
Italy (IT)
Sweden (SE)
Norway (NO)
Finland (FI)
Poland (PL)
Slovenia (SI)
许可日期
2009/10/29
最近更新日期
2024/11/15
药物ATC编码
L04AA05 Tacrolimus
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
1_3_1 spc_label_pl _ common_pl _ clean
Date of last change:2024/09/06
Final Product Information
|
1_3_1 spc_label_pl _ common_spc _ 6_931 _clean
Date of last change:2024/09/06
Final PL
|
Adport_common_pl
Date of last change:2024/09/06
Final SPC
|
Adport_common_spc
Date of last change:2024/09/06
Final Product Information
|
common_outer_clean
Date of last change:2024/09/06
PubAR
|
PAR_1340_tacrolimus_DC_1 feb 2010
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase